Which drug has the maximum propensity to cause peripheral neuropathy?
Isoniazid (INH) can be used safely in the presence of which of the following conditions?
Which of the following drugs requires no or minor adjustment in renal failure?
What is the chemoprophylaxis dose of chloroquine?
Which of the following antimicrobial agents is least nephrotoxic?
Albendazole may be used for treatment of all of the following conditions except?
Which of the following agents is active against atypical mycobacteria?
All of the following are common adverse effects of HAART therapy except?
Which of the following statements regarding vancomycin is true?
Ototoxicity and nephrotoxicity may be a side effect of which of the following medications?
Explanation: **Explanation:** The correct answer is **Stavudine (d4T)**. **1. Why Stavudine is correct:** Stavudine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI). The primary mechanism behind its side effects is **mitochondrial toxicity**. NRTIs can inhibit **DNA polymerase-gamma**, the enzyme responsible for mitochondrial DNA replication. Among all NRTIs, Stavudine has the highest affinity for this enzyme, leading to significant mitochondrial dysfunction. This manifests clinically as severe **peripheral neuropathy** (stocking-glove pattern) and lipodystrophy. **2. Analysis of Incorrect Options:** * **Didanosine (ddI):** Also causes peripheral neuropathy and pancreatitis due to mitochondrial toxicity, but its propensity is lower than that of Stavudine. * **Zidovudine (AZT):** Its hallmark toxicity is **bone marrow suppression** (anemia and neutropenia) and myopathy, rather than peripheral neuropathy. * **Lamivudine (3TC):** This is one of the least toxic NRTIs. It is generally well-tolerated and rarely associated with significant peripheral neuropathy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Neuropathy:** "The **D** drugs cause **D**amage to nerves" (**D**idanosine, **D**eoxycytidine/Zalcitabine, and Stavudine/**d**4T). * **Stavudine + Didanosine:** This combination is strictly avoided because it synergistically increases the risk of peripheral neuropathy and life-threatening lactic acidosis. * **Lactic Acidosis:** This is a class-wide adverse effect of NRTIs, also due to mitochondrial inhibition. * **Zidovudine:** Known for causing nail hyperpigmentation and macrocytic anemia.
Explanation: **Explanation:** Isoniazid (INH) is a cornerstone of Antitubercular Therapy (ATT), but its clinical use is limited by specific toxicities. Understanding its metabolism and side-effect profile is crucial for determining its safety in various comorbidities. **1. Why Coronary Artery Disease (CAD) is the correct answer:** Isoniazid does not have significant cardiotoxic effects. It does not alter heart rate, blood pressure, or myocardial oxygen demand, nor does it exacerbate atherosclerosis. Therefore, it can be used safely in patients with CAD without dose adjustment or increased risk of cardiac events. **2. Why the other options are incorrect:** * **Jaundice (Option A):** INH is primarily metabolized in the liver via **acetylation**. It is a known hepatotoxin that can cause asymptomatic elevation of transaminases or overt hepatitis. In the presence of jaundice (suggesting hepatic dysfunction), INH is contraindicated or must be used with extreme caution. * **Chronic Renal Failure (Option B):** While INH is mainly metabolized by the liver, its metabolites are excreted by the kidneys. In severe renal failure, there is a risk of accumulation. More importantly, renal failure increases the risk of **peripheral neuropathy**, a major side effect of INH. * **Epilepsy (Option C):** INH inhibits the synthesis of GABA (an inhibitory neurotransmitter) by interfering with Pyridoxine (Vitamin B6) metabolism. This lowers the seizure threshold and can precipitate convulsions in patients with pre-existing epilepsy. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits **Mycolic acid synthesis** by targeting the *inhA* gene. * **Metabolism:** Shows **Genetic Polymorphism** (Fast vs. Slow Acetylators). Slow acetylators are more prone to peripheral neuropathy. * **Prophylaxis:** To prevent peripheral neuropathy, always co-administer **Pyridoxine (10–40 mg/day)**. * **Drug Interaction:** INH is a potent **Enzyme Inhibitor** (increases levels of Phenytoin, Carbamazepine, and Warfarin).
Explanation: ### Explanation The management of antimicrobial therapy in patients with renal impairment requires a thorough understanding of drug excretion pathways. Drugs primarily excreted via the kidneys require significant dose adjustments to prevent toxicity, while those excreted via the liver (biliary/fecal) generally do not. **Why Vancomycin is the Correct Answer (Contextual Note):** In the context of standard pharmacological teaching for NEET-PG, **Vancomycin** is notoriously **renally excreted** and requires strict dose adjustment and Therapeutic Drug Monitoring (TDM) to avoid nephrotoxicity and ototoxicity. *Note: There appears to be a discrepancy in the provided key. Traditionally, **Doxycycline, Chloramphenicol, and Clindamycin** are the classic examples of drugs requiring **no adjustment** in renal failure because they are primarily metabolized by the liver or excreted via feces.* **Analysis of Options:** * **Doxycycline (Option A):** The safest tetracycline in renal failure. It is excreted primarily via the bile into the feces (enterohepatic circulation), making it the drug of choice for MRSA or atypical infections in uremic patients. * **Vancomycin (Option B):** **Incorrect as a "no adjustment" drug.** It is eliminated >80% unchanged by glomerular filtration. In renal failure, its half-life extends significantly (from 6 hours to several days), necessitating major dose intervals or reduction. * **Chloramphenicol (Option C):** Primarily metabolized by hepatic glucuronidation. No dosage adjustment is needed in renal failure (though it is rarely used now due to toxicity). * **Clindamycin (Option D):** Primarily metabolized by the liver. No adjustment is required in renal impairment. **High-Yield Clinical Pearls for NEET-PG:** * **Safe in Renal Failure (No adjustment):** "DR. C" mnemonic — **D**oxycycline, **R**ifampin, **C**ephriaxone, **C**lindamycin, **C**hloramphenicol. * **Avoid in Renal Failure:** Tetracyclines (except Doxycycline), Aminoglycosides, Nitrofurantoin (ineffective), and Ethambutol. * **Vancomycin TDM:** Always monitor "trough levels" to ensure efficacy and minimize nephrotoxicity.
Explanation: **Explanation:** Chloroquine is a 4-aminoquinoline used for the prophylaxis and treatment of malaria in areas where the parasite remains sensitive. **1. Why Option D is correct:** The standard chemoprophylaxis dose for an adult is **300 mg (base) once weekly**. This dose is equivalent to 500 mg of chloroquine phosphate. Prophylaxis should ideally start 1–2 weeks before entering an endemic area, continue weekly during the stay, and persist for 4 weeks after leaving the area. This regimen maintains a steady-state therapeutic concentration in the blood to eliminate erythrocytic forms of *Plasmodium* (suppressive prophylaxis). **2. Why other options are incorrect:** * **Option A (300 mg twice weekly):** This is not a standard prophylactic regimen and would increase the risk of cumulative toxicity, such as retinal damage. * **Option B & C (600 mg weekly):** 600 mg (base) is the **loading dose** used in the treatment of an acute attack of malaria, not for prophylaxis. Using this dose weekly would lead to significant gastrointestinal and neurological side effects. **Clinical Pearls for NEET-PG:** * **Mechanism:** It inhibits the heme polymerase enzyme, leading to the accumulation of toxic heme within the parasite. * **Safe in Pregnancy:** Chloroquine is the drug of choice for malaria prophylaxis and treatment in pregnant women (in sensitive areas). * **Adverse Effects:** Long-term use requires monitoring for **bull’s eye retinopathy** (irreversible) and cardiomyopathy. * **Contraindications:** Avoid in patients with G6PD deficiency (risk of hemolysis), psoriasis (may exacerbate skin lesions), and epilepsy.
Explanation: ### Explanation The correct answer is **Doxycycline (Option D)**. **1. Why Doxycycline is the Correct Answer:** Doxycycline is a tetracycline derivative that is unique because it is primarily excreted through the **biliary tract (feces)** rather than the kidneys. It undergoes significant enterohepatic circulation and is eliminated as an inactive chelate in the stool [2]. Because it does not accumulate in the blood even in patients with renal failure, it is considered the **safest tetracycline for patients with renal impairment** and is virtually non-nephrotoxic. **2. Why the Other Options are Incorrect:** * **Gentamicin (Option B):** Aminoglycosides are notorious for causing **Acute Tubular Necrosis (ATN)**. Gentamicin is highly nephrotoxic because it accumulates in the proximal convoluted tubule cells [1]. * **Streptomycin (Option A):** While Streptomycin is generally considered the least nephrotoxic among the aminoglycosides, it still carries a significant risk of renal damage compared to Doxycycline [1]. * **Polymyxin B (Option C):** Polymyxins act like detergents on cell membranes. They are highly nephrotoxic and neurotoxic; their systemic use is often limited by their tendency to cause severe renal tubular damage. **3. High-Yield Clinical Pearls for NEET-PG:** * **"D" for Doxycycline = "D" for Does not** accumulate in the kidney. * **Tetracycline to avoid in renal failure:** All tetracyclines (especially Tetracycline and Oxytetracycline) are contraindicated in renal failure due to their anti-anabolic effect, which increases BUN (Azotemia). **Doxycycline is the sole exception.** [2] * **Drug of Choice:** Doxycycline is the drug of choice for Chlamydia, Rickettsial infections (Rocky Mountain Spotted Fever), and Brucellosis (with Rifampicin) [2]. * **Fanconi Syndrome:** Expired tetracyclines cause a form of nephrotoxicity known as Fanconi Syndrome (proximal renal tubular acidosis).
Explanation: **Explanation:** The correct answer is **Schistosomiasis** because Albendazole is primarily an **anti-nematodal** drug, whereas Schistosomiasis is caused by **trematodes** (blood flukes). [3] **1. Why Schistosomiasis is the correct "Except" option:** Albendazole works by inhibiting microtubule synthesis (binding to β-tubulin) in nematodes. However, it has negligible activity against *Schistosoma* species. The drug of choice for all forms of Schistosomiasis is **Praziquantel**, which works by increasing calcium permeability, leading to paralysis and tegumental damage of the fluke. [3] **2. Why the other options are incorrect:** Albendazole is a broad-spectrum anthelmintic highly effective against common intestinal nematodes: [1] * **Enterobiasis (Pinworm):** Albendazole is a first-line treatment (single dose, repeated after 2 weeks). [1] * **Ankylostomiasis (Hookworm):** It is highly effective against both *Ancylostoma duodenale* and *Necator americanus*. [1] * **Ascariasis (Roundworm):** It is the drug of choice for *Ascaris lumbricoides*. [1] **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits microtubule polymerization by binding to β-tubulin; also inhibits glucose uptake in parasites. [2] * **Drug of Choice (DOC):** Albendazole is the DOC for **Neurocysticercosis** (caused by *Taenia solium* larvae) and **Hydatid disease** (caused by *Echinococcus granulosus*). [2] * **Absorption:** Its absorption is significantly **increased when taken with a fatty meal**, which is crucial when treating systemic infections like Hydatid cysts. * **Teratogenicity:** It is generally avoided in pregnancy (Category C).
Explanation: **Explanation:** Atypical mycobacteria, also known as **Non-Tuberculous Mycobacteria (NTM)** (e.g., *Mycobacterium avium complex* [MAC], *M. kansasii*, *M. marinum*), differ from *M. tuberculosis* in their susceptibility patterns. They are often resistant to standard first-line anti-tubercular drugs (HRZE) but respond to a combination of macrolides, rifamycins, and fluoroquinolones. * **Clarithromycin (Option A):** This is the **drug of choice** for both the treatment and prophylaxis of *Mycobacterium avium complex* (MAC). It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. * **Rifabutin (Option B):** A derivative of Rifampin, it is significantly more active against atypical mycobacteria. It is frequently used for MAC prophylaxis in HIV patients with low CD4 counts because it has a longer half-life and fewer cytochrome P450 drug interactions than rifampin. * **Ciprofloxacin (Option C):** Fluoroquinolones exhibit potent bactericidal activity against various NTMs, particularly *M. kansasii* and *M. fortuitum*, by inhibiting DNA gyrase. Since all three classes of drugs listed are clinically utilized in the management of atypical mycobacterial infections, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **MAC Prophylaxis:** Started in HIV patients when **CD4 count < 50 cells/mm³**. Azithromycin or Clarithromycin are preferred. * **Buruli Ulcer:** Caused by *M. ulcerans*; treated with Rifampicin + Streptomycin/Clarithromycin. * **Fish Tank Granuloma:** Caused by *M. marinum*; often treated with Clarithromycin or Minocycline. * **Rapid Growers:** *M. fortuitum, M. chelonae, and M. abscessus* are often sensitive to Amikacin and Clarithromycin.
Explanation: Highly Active Antiretroviral Therapy (HAART) is associated with a specific cluster of metabolic and mitochondrial toxicities. **Explanation of the Correct Answer:** **Optic neuritis (Option C)** is **not** a common adverse effect of HAART. While it is a classic side effect of **Ethambutol** (used in TB) or certain infections like CMV in HIV patients, it is not typically caused by antiretroviral drugs. **Explanation of Incorrect Options:** * **Steatosis (Option A):** Nucleoside Reverse Transcriptase Inhibitors (NRTIs), especially Zidovudine, Stavudine, and Didanosine, cause **mitochondrial toxicity** by inhibiting DNA polymerase-gamma. This leads to lactic acidosis and hepatic steatosis (fatty liver). * **Lipodystrophy (Option B):** This is a hallmark side effect of HAART, characterized by "Cushingoid" fat redistribution (buffalo hump, abdominal obesity) and peripheral fat wasting. It is most commonly associated with **Protease Inhibitors (PIs)** and certain NRTIs (Stavudine). * **Increased Cholesterol (Option D):** Dyslipidemia (elevated triglycerides and LDL) is a very common metabolic complication of **Protease Inhibitors** (e.g., Ritonavir, Lopinavir), which interfere with lipid metabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for NRTI toxicity:** "L-M-N" (Lactic acidosis, Mitochondrial toxicity, Nucleoside analogs). * **Zidovudine:** Most common side effect is **Anemia/Bone marrow suppression**. * **Abacavir:** Associated with **Hypersensitivity reactions** (linked to HLA-B*5701). * **Nevirapine:** Known for causing **Stevens-Johnson Syndrome (SJS)** and hepatotoxicity. * **Indinavir:** Associated with **Nephrolithiasis** (kidney stones). * **Tenofovir:** Can cause **Fanconi syndrome** (renal tubular acidosis).
Explanation: **Explanation:** **1. Why Option C is Correct:** Vancomycin is a **glycopeptide antibiotic**, not a beta-lactam. It inhibits cell wall synthesis by binding directly to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide. Because its chemical structure and mechanism of action are entirely different from penicillins, it is not a substrate for **penicillinases (beta-lactamases)**. This makes it highly effective against beta-lactamase-producing organisms like MRSA. **2. Why the Other Options are Incorrect:** * **Option A:** Vancomycin is **bactericidal** for most susceptible organisms (except for Enterococci, where it is bacteriostatic). It kills bacteria by preventing the cross-linking of the peptidoglycan layer. * **Option B:** It has **poor oral bioavailability** (<1%). It is almost exclusively administered intravenously for systemic infections. Oral administration is reserved strictly for local action within the gut (e.g., *C. difficile* colitis). * **Option D:** Staphylococcal enterocolitis is not a common side effect. In fact, oral vancomycin is a **treatment** for pseudomembranous colitis caused by *Clostridioides difficile*. **3. High-Yield Clinical Pearls for NEET-PG:** * **Red Man Syndrome:** A common infusion-related reaction (not an allergy) caused by rapid IV injection leading to histamine release. Prevented by slowing the infusion rate. * **Mechanism of Resistance:** Alteration of the binding site from **D-Ala-D-Ala to D-Ala-D-Lac** (seen in VRSA/VRE). * **Spectrum:** Exclusively Gram-positive coverage (too large to pass through Gram-negative porins). * **Toxicity:** Primarily **Ototoxicity** and **Nephrotoxicity** (especially when combined with aminoglycosides).
Explanation: **Explanation:** **Vancomycin** is a glycopeptide antibiotic primarily used for MRSA and other resistant Gram-positive infections. Its most significant dose-related toxicities are **nephrotoxicity** (renal impairment) and **ototoxicity** (vestibular or auditory damage). These risks are significantly increased when Vancomycin is administered concurrently with other ototoxic or nephrotoxic drugs, such as Aminoglycosides or Loop diuretics. Another high-yield side effect is **"Red Man Syndrome,"** an infusion-related reaction caused by histamine release. **Analysis of Incorrect Options:** * **Azithromycin (Macrolide):** While macrolides can rarely cause reversible hearing loss at very high doses, they are primarily associated with GI upset, QT prolongation, and cholestatic hepatitis. They are not nephrotoxic. * **Clindamycin (Lincosamide):** The classic side effect associated with Clindamycin is pseudomembranous colitis caused by *Clostridioides difficile* overgrowth. It does not typically cause ear or kidney damage. * **Penicillin (Beta-lactam):** The most common adverse effects are hypersensitivity reactions (Type I IgE-mediated). High doses can cause neurotoxicity (seizures) or interstitial nephritis, but not ototoxicity. **NEET-PG High-Yield Pearls:** * **Mnemonic for Vancomycin Side Effects:** **NOT** (Nephrotoxicity, Ototoxicity, Thrombophlebitis). * **Therapeutic Drug Monitoring (TDM):** Essential for Vancomycin to maintain trough levels (usually 15–20 µg/mL) to prevent toxicity. * **Other drugs causing both Ototoxicity & Nephrotoxicity:** Aminoglycosides (e.g., Gentamicin), Amphotericin B, and Cisplatin.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free